iPremom is a Spanish molecular diagnostics company addressing the early identification of pregnancy complications.
iPremom has raised €15M across 1 funding round from 3 investors, most recently a Seed round in Sep 2026. Based in Paterna, Spain; active in Healthtech. Data as of 2 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-02 | Seed | €15M |
| Amadeus Capital Partners,APEX Ventures,Asabys Partners |
| View deal → |
